Clinical Trials Arena March 20, 2024
Various data indicates that the healthcare industry is reaching a critical point.
A report published by the US Food and Drug Administration (FDA) in 2019 titled ‘Drug shortages; Root Causes and Potential Solutions?’ identified the lack of incentives for manufacturers to produce less profitable drugs as one of the root causes of drug shortages.
This report remains relevant five years later as the industry is still plagued by these challenges.
They were also a popular topic at the Clinical Trial Supply 2024 conference held in Barcelona, Spain, on 6-7 May, where Thomas Thoma, head of Managed Access Programs – Clinical Trial Supply, Global Health Tendering and Global Shortages, explored why this issue is still pertinent and the impact these shortages...
Today's Sponsors
Today's Sponsor